Literature DB >> 17178427

Successful decolonization of methicillin-resistant Staphylococcus aureus in paediatric patients with cystic fibrosis (CF) using a three-step protocol.

M Macfarlane1, A Leavy, J McCaughan, R Fair, A J M Reid.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is recognized as a bacterial pathogen in patients with cystic fibrosis (CF) although its clinical effects can be variable. The aim of this study was to evaluate the efficacy of a three-step decolonization protocol for MRSA (Belfast CF MRSA decolonization protocol). Of the 17 paediatric patients treated during the five years of the study, eight (47%) were successfully decolonized following one five-day course of oral rifampicin and fusidic acid. The success rate increased to 12 (71%) patients after a second five-day oral treatment course in the 11 patients who remained culture positive at the end of the first treatment cycle. In a further four patients, clearance was achieved with a course of intravenous teicoplanin, increasing the decolonization rate to 16 of 17 patients (94%). These results compare favourably with other published studies and show that MRSA decolonization can be successful in a high proportion of paediatric CF patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178427     DOI: 10.1016/j.jhin.2006.10.011

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  15 in total

1.  Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.

Authors:  Marianne Sponer Muhlebach; Valeria Beckett; Elena Popowitch; Melissa B Miller; Arthur Baines; Nicole Mayer-Hamblett; Edith T Zemanick; Wynton C Hoover; Jill M VanDalfsen; Preston Campbell; Christopher H Goss
Journal:  Thorax       Date:  2016-11-15       Impact factor: 9.139

Review 2.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 3.  Targeting airway inflammation in cystic fibrosis in children: past, present, and future.

Authors:  Tacjana Pressler
Journal:  Paediatr Drugs       Date:  2011-06-01       Impact factor: 3.022

4.  Prevalence and impact of Streptococcus pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study.

Authors:  Christina S Thornton; Erin L Brown; Joenel Alcantara; Harvey R Rabin; Michael D Parkins
Journal:  BMC Pulm Med       Date:  2015-05-02       Impact factor: 3.317

Review 5.  Treatment of pseudomonas and Staphylococcus bronchopulmonary infection in patients with cystic fibrosis.

Authors:  Rashmi Ranjan Das; Sushil Kumar Kabra; Meenu Singh
Journal:  ScientificWorldJournal       Date:  2013-12-30

6.  Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis--the PMEP trial: study protocol for a randomized controlled trial.

Authors:  Mark T Jennings; Michael P Boyle; David Weaver; Karen A Callahan; Elliott C Dasenbrook
Journal:  Trials       Date:  2014-06-12       Impact factor: 2.279

7.  MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis.

Authors:  Emilie Vallières; Jacqueline C Rendall; John E Moore; John McCaughan; Anne I Hoeritzauer; Michael M Tunney; Joseph Stuart Elborn; Damian G Downey
Journal:  ERJ Open Res       Date:  2016-03-15

8.  Brazilian guidelines for the diagnosis and treatment of cystic fibrosis.

Authors:  Rodrigo Abensur Athanazio; Luiz Vicente Ribeiro Ferreira da Silva Filho; Alberto Andrade Vergara; Antônio Fernando Ribeiro; Carlos Antônio Riedi; Elenara da Fonseca Andrade Procianoy; Fabíola Villac Adde; Francisco José Caldeira Reis; José Dirceu Ribeiro; Lídia Alice Torres; Marcelo Bicalho de Fuccio; Matias Epifanio; Mônica de Cássia Firmida; Neiva Damaceno; Norberto Ludwig-Neto; Paulo José Cauduro Maróstica; Samia Zahi Rached; Suzana Fonseca de Oliveira Melo
Journal:  J Bras Pneumol       Date:  2017 May-Jun       Impact factor: 2.624

Review 9.  Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.

Authors:  David Kh Lo; Marianne S Muhlebach; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2018-07-21

10.  Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme.

Authors:  Alexander Kiefer; Christian Bogdan; Volker O Melichar
Journal:  BMC Pulm Med       Date:  2018-01-25       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.